BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prajna, N V
Right arrow Articles by Srinivasan, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prajna, N V
Right arrow Articles by Srinivasan, M
British Journal of Ophthalmology 2003;87:1235-1237
© 2003 BMJ Publishing Group Ltd


EXTENDED REPORT

A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis

N V Prajna1, R K John1,2, P K Nirmalan1,2, P Lalitha1, M Srinivasan1

1 Aravind Eye Care System, Madurai, India
2 Lions Aravind Institute of Community Ophthalmology, Madurai, India

Correspondence to:
Correspondence to:
N Venkatesh Prajna, Cornea Service, Aravind Eye Care System, 1 Anna Nagar, Madurai-625020, India;
prajna{at}aravind.org

Aim: To compare 2% econazole and 5% natamycin in the management of fungal keratitis.

Methods: A randomised clinical trial was performed using 2% econazole or 5% natamycin as the two treatment arms on patients presenting with culture positive fungal keratitis to the cornea service at Aravind Eye Care System, Madurai, India.

Results: 116 patients were recruited, and 112 continued in the study. There were no significant differences between the two arms at baseline or for success (defined as a healed or healing ulcer) at final visit (p = 0.79).

Conclusions: 2% Econazole appears to be as effective as 5% natamycin for the management of fungal keratitis.


Keywords: fungal keratitis; randomised clinical trial; econazole; natamycin




This article has been cited by other articles:


Home page
Arch OphthalmolHome page
G. A. Vemulakonda, S. M. Hariprasad, W. F. Mieler, R. A. Prince, G. K. Shah, and R. N. Van Gelder
Aqueous and Vitreous Concentrations Following Topical Administration of 1% Voriconazole in Humans
Arch Ophthalmol, January 1, 2008; 126(1): 18 - 22.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
P. Lalitha, B. L. Shapiro, M. Srinivasan, N. V. Prajna, N. R. Acharya, A. W. Fothergill, J. Ruiz, J. D. Chidambaram, K. J. Maxey, K. C. Hong, et al.
Antimicrobial Susceptibility of Fusarium, Aspergillus, and Other Filamentous Fungi Isolated From Keratitis
Arch Ophthalmol, June 1, 2007; 125(6): 789 - 793.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 by the BMJ Publishing Group Ltd.